만성 저등급 염증이론을 바탕으로 한 건선의 한약치료에 대한 문헌고찰

키워드

참고문헌 (60)

1. Gelfand JM, "Prevalence and treatment of psoriasis in the United Kingdom: a population-based study", Arch Dermatol, 141(12), pp.1537~1541 (2005)
2. Kremers HM, "Heart disease in psoriasis", J Am Acad Dermatol, 57(2), pp.347~354 (2007)
3. Neimann AL, "Prevalence of cardiovascular risk factors in patients with psoriasis", J Am Acad Dermatol, 55(5), pp.829~835 (2006)
4. Heymann WR, "Psoriasis: the heart of the matter", J Am Acad Dermatol, 58(3), pp.477~478 (2008)
5. Griffiths CE, "Update on the use of ciclosporin in immune-mediated dermatoses", Br J Dermatol, 155(Suppl 2), pp.1~16 (2006)
6. Gelfand JM, "Epidemiology of psoriatic arthritis in the population of the United States", J Am Acad Dermatol, 53(4), pp.573~ (2005)
7. Strober B, "Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis", Br J Dermatol, 159(2), pp.322~330 (2008)
8. Ross R, "Atherosclerosis—an inflammatory disease", N Engl J Med, 340(2), pp.115~126 (1999)
9. Fernández-Sánchez A, "Inflammation, oxidative stress, and obesity", Int J Mol Sci, 12(5), pp.3117~3132 (2011)
10. Berk M, "So depression is an inflammatory disease, but where does the inflammation come from?", BMC Med, 11, pp.200~ (2013)
11. McArdle MA, "Mechanisms of obesity-induced inflammation and insulin resistance:insights into the emerging role of nutritional strategies", Front Endocrinol(Lausanne), 4, pp.52~ (2013)
12. Heymsfield SB, "Mechanisms, Pathophysiology, and Management of Obesity", N Engl J Med, 376(15), pp.1492~ (2017)
13. Liu C, "Chinese Herbal Medicine on Cardiovascular Diseases and the Mechanisms of Action", Front Pharmacol, 7, pp.469~ (2016)
14. Sommer DM, "Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis", Arch Dermatol Res, 298(7), pp.321~328 (2006)
15. Henseler T, "Disease concomitance in psoriasis", J Am Acad Dermatol, 32(6), pp.982~986 (1995)
16. Christophers E, "Comorbidities in psoriasis", Clin Dermatol, 25(6), pp.529~534 (2007)
17. Medzhitov R, "Origin and physiological roles of inflammation", Nature, 454(7203), pp.428~435 (2008)
18. Rainer H. Straub, "Chronic inflammatory systemic diseases: An evolutionary trade-off betweenacutely beneficial but chronically harmful programs", Evol Med Public Health, 2016(1), pp.37~51 (2016)
19. Netea MG, "A guiding map for inflammation", Nat Immunol, 18(8), pp.826~831 (2017)
20. Rapp SR, "Psoriasis causes as much disability as other major medical diseases", J Am Acad Dermatol, 41, pp.401~407 (1999)
21. Nestle FO, "Psoriasis", N Engl J Med, 361(5), pp.496~509 (2009)
22. Parisi R, "Global epidemiology of psoriasis: a systematic review of incidence and prevalence", J Invest Dermatol, 133(2), pp.377~385 (2013)
23. Michalek IM, "A systematic review of worldwide epidemiology of psoriasis", J Eur Acad Dermatol Venereol, 31(2), pp.205~212 (2017)
24. Franceschi C, "Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases", J Gerontol A Biol Sci Med Sci, 69, pp.4~9 (2014)
25. Rousset L, "Stress and psoriasis", Int J Dermatol, 57(10), pp.1165~1172 (2018)
26. Zachariae R, "Self-reportedstress reactivity and psoriasis-related stress of nordic psoriasissufferers", J Eur Acad Dermatol Venereol, 18(1), pp.27~36 (2004)
27. Song H, "Association of Stress-Related Disorders With Subsequent Autoimmune Disease", JAMA, 319(23), pp.2388~2400 (2018)
28. Correia B, "Obesity: a key component of psoriasis", Acta Biomed, 86(2), pp.121~129 (2015)
29. Armstrong AW, "The association between psoriasis and obesity: a systematic review and metaanalysis of observational studies", Nutr Diabetes, 2, pp.e54~ (2012)
30. Dogra S, "Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring", Indian Dermatol Online J, 7(6), pp.471~480 (2016)
31. Mason JC, "Cardiovascular disease in patients with chronic inflammation:mechanisms underlying premature cardiovascular events in rheumatologic conditions", Eur Heart J, 36(8), pp.482~489c (2015)
32. Reich K, "The concept of psoriasis as a systemic inflammation: implications for disease management", J Eur Acad Dermatol Venereol, 26, pp.3~11 (2012)
33. Ridker PM, "High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease", Circulation, 103(13), pp.1813~1818 (2001)
34. Bassuk SS, "High-sensitivity C-reactive protein: clinical importance", Curr Probl Cardiol, 29(8), pp.439~493 (2004)
35. Mora S, "Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women", JAMA, 295(12), pp.1412~1419 (2006)
36. Strober B, "Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis", Br J Dermatol, 159(2), pp.322~330 (2008)
37. Sterry W, "Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review", Br J Dermatol, 157(4), pp.649~655 (2007)
38. Vandevoorde V, "TNF-mediated IL6 gene expression and cytotoxicity are co-inducible in TNFresistant L929 cells", FEBS Lett, 302(3), pp.235~238 (1992)
39. Naldi L, "Association of Early-Stage Psoriasis With Smoking and Male Alcohol Consumption: evidence From an Italian Case-Control Study", Arch Dermatol, 135(12), pp.1479~1484 (1999)
40. Davidovici BB, "Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions", J Invest Dermatol, 130(7), pp.1785~1796 (2010)
41. Ryan C, "Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities", Dermatol Clin, 33(1), pp.41~55 (2015)
42. Greb JE, "Psoriasis", Nat Rev Dis Primers, 2, pp.16082~ (2016)
43. Meng S, "Psoriasis therapy by Chinese medicine and modern agents", Chin Med, 13, pp.16~ (2018)
44. Guan F, "Majority of Chinese Medicine Herb Category "Qing Re Yao" Have Multiple Mechanisms of Antiinflammatory Activity", Sci Rep, 8(1), pp.7416~ (2018)
45. Cheng H-M, "Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasis", BMC Complement Altern Med, 17(1), pp.439~ (2017)
46. De Sá DC, "Inflammasomes and dermatology", An Bras Dermatol, 91(5), pp.566~578 (2016)
47. Tőzsér J, "Natural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL-1β Production", Mediators Inflamm, 2016, pp.5460302~ (2016)
48. Lin X, "Oxidative stress in psoriasis and potential therapeutic use of antioxidants", Free Radic Res, 50(6), pp.585~595 (2016)
49. Hirayama A, "Clinical significance of redox effects of Kampo formulae, a traditional Japanese herbal medicine: comprehensive estimation of multiple antioxidative activities", J Clin Biochem Nutr, 62(1), pp.39~48 (2018)
50. Wang D, "PDTCM: a systems pharmacology platform of traditional Chinese medicine for psoriasis", Ann Med, 49(8), pp.652~660 (2017)
51. Wu M, "The Immunoregulatory Effects of Traditional Chinese Medicine on Psoriasis via its Action on Interleukin: Advances and Considerations", Am J Chin Med, 46(4), pp.739~750 (2018)
52. Lin YK, "A Chinese Herb, Indigo Naturalis, Extracted in Oil(Lindioil)Used Topically to Treat Psoriatic Nails : A Randomized Clinical Trial", JAMA Dermatol, 151(6), pp.672~674 (2015)
53. Yan Y, "Exploratory clinical trial to evaluate the efficacy of a topical traditional chinese herbal medicine in psoriasis vulgaris", Evid Based Complement Alternat Med, 2015, pp.719641~ (2015)
54. Lin YK, "Comparison of indirubin concentrations in indigo naturalis ointment for psoriasis treatment:a randomized, double-blind, dosage-controlled trial", Br J Dermatol, 178(1), pp.124~131 (2018)
55. Sun W, "'Psoriasis 1'reduces psoriasis‑like skin inflammation by inhibiting the VDR‑mediated nuclear NF‑κB and STAT signaling pathways", Mol Med Rep, 18(3), pp.2733~2743 (2018)
56. Lu C, "Herbal Components of a Novel Formula PSORI-CM02 Interdependently Suppress Allograft Rejection and Induce CD8+CD122+PD-1+ Regulatory T Cells", Front Pharmacol, 9, pp.88~ (2018)
57. Liu Q, "Diarylheptanoid from rhizomes of Curcuma kwangsiensis (DCK) inhibited imiquimod-induced dendritic cells activation and Th1", Th17differentiation, 2018, pp.56, 339~348
58. Geng X, "Matrine inhibits itching by lowering the activity of calcium channel", Sci Rep, 8(1), pp.11328~ (2018)
59. Parker S, "Oral Chinese herbal medicine versus placebo for psoriasis vulgaris: A systematic review", J Dermatolog Treat, 28(1), pp.21~31 (2017)
60. Zhang CS, "Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin", J Altern Complement Med, 22(3), pp.174~188 (2016)